Effects of mild processing pressures on the performance of dry powder inhaler formulations for inhalation therapy (1): Budesonide and lactose

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 78, Issue 1, 2011, Pages 97-106

  Marek, Steve R ^a   Donovan, Martin J ^a   Smyth, Hugh D C ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Batch to batch variation; Budesonide; Compression; Dry powder inhalers; Formulations; Lactose

Indexed keywords

BUDESONIDE; LACTOSE;

AEROSOL; ARTICLE; COMPRESSION; CONTROLLED STUDY; DRUG FORMULATION; DRY POWDER; FLOW MEASUREMENT; PARTICLE SIZE; POWDER INHALER;

ADMINISTRATION, INHALATION; BUDESONIDE; LACTOSE; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; POWDERS;

EID: 79953161005     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2010.12.020     Document Type: Article

References (27)

1. S. Newman Evolution of dry powder inhaler design Formul. Perform. Respir. Med. 96 2002 293 304
2. H. Smyth, Excipients for pulmonary formulations, in: A. Katdare, M.V. Chau (Eds.), Excipient Development for Pharmaceutical, Biotechnology, and Drug Delivery Systems, Informa Healthcare, 2010, p. 225.
3. D.S. Phadke Evaluation of batch-to-batch and manufacturer-to-manufacturer variability in the physical properties of talc and stearic acid Drug Dev. Ind. Pharm. 20 1994 859 871 (Pubitemid 24141760)
4. P. Maincent The interchangeability of excipient formulations and the eventual consequences Therapie 54 1999 5 10 (Pubitemid 29145964)
5. T. Sam Regulatory implications of excipient changes in medicinal products Drug Inf. J. 34 2000 875 894 (Pubitemid 30659520)
6. R. Vippagunta Application of surface area measurement for identifying the source of batch-to-batch variation in processability Pharm. Dev. Technol. 14 2009 492 498
7. D. Craig Characterization of the variation between batches of fast-flo lactose using low-frequency dielectric-spectroscopy J. Pharm. Pharmacol. 43 1991 444 445
8. M. Ticehurst Characterisation of the surface properties of alpha-lactose monohydrate with inverse gas chromatography, used to detect batch variation Int. J. Pharm. 141 1996 93 99 (Pubitemid 26302915)
9. S.P. Chamarthy Elucidating raw material variability - importance of surface properties and functionality in pharmaceutical powders AAPS PharmSciTech 10 2009 780 788
10. M. Whiteman, and R.J. Yarwood Variations in lactose nf from two different sources and their influence on tablet properties Drug Dev. Ind. Pharm. 16 1990 1815 1827 (Pubitemid 20230585)
11. M. Landín The effect of country of origin on the properties of dicalcium phosphate dihydrate powder Int. J. Pharm. 103 1994 9 18 (Pubitemid 24035810)
12. M. Landín Effect of country of origin on the properties of microcrystalline cellulose Int. J. Pharm. 91 1993 123 131 (Pubitemid 23159815)
13. M. Parker Binder-substrate interactions in wet granulation. 3: The effect of excipient source variation Int. J. Pharm. 80 1992 179 190
14. A.J. Hickey Physical characterization of component particles included in dry powder inhalers. I. Strategy review and static characteristics J. Pharm. Sci. 96 2007 1282 1301 (Pubitemid 46804582)
15. Chem-Tainer Industries, Inc., 30 cu. ft. hopper (.312 wall thk.).
16. H.A. Janssen Versuche uber getreidedruck in silozellen Z. Ver. Dtsch. Ing. 39 1895 1045
17. J.M. Rotter Guide for the Economic Design of Circular Metal Silos 2001 Taylor & Francis New York
18. J. Nordström On the role of granule yield strength for the compactibility of granular solids J. Pharm. Sci. 97 2008 4807 4814
19. V. Busignies Changes in the specific surface area of tablets composed of pharmaceutical materials with various deformation behaviors Drug Dev. Ind. Pharm. 2010 1 9
20. E. Doelker Assessment of powder compaction D. Chulia, Powder Technology and Pharmaceutical Process 1994 Elsevier Amsterdam 403 471
21. N. Concessio Pharmaceutical dry powder aerosols: correlation of powder properties with dose delivery and implications for pharmacodynamic effect Pharm. Res. 16 1999 828 834 (Pubitemid 29284192)
22. P. Lucas Protein deposition from dry powder inhalers: fine particle multiplets as performance modifiers Pharm. Res. 15 1998 562 569 (Pubitemid 28214949)
23. M. Louey, and P. Stewart Particle interactions involved in aerosol dispersion of ternary interactive mixtures Pharm. Res. 19 2002 1524 1531 (Pubitemid 35266558)
24. X. Zeng The role of fine particle lactose on the dispersion and deaggregation of salbutamol sulphate in an air stream in vitro Int. J. Pharm. 176 1998 99 110 (Pubitemid 28544976)
25. X. Zeng Effects of particle size and adding sequence of fine lactose on the deposition of salbutamol sulphate from a dry powder formulation Int. J. Pharm. 182 1999 133 144 (Pubitemid 29248842)
26. N. Islam Lactose surface modification by decantation: are drug-fine lactose ratios the key to better dispersion of salmeterol xinafoate from lactose-interactive mixtures? Pharm. Res. 21 2004 492 499 (Pubitemid 38338985)
27. H. Steckel Effect of milling and sieving on functionality of dry powder inhalation products Int. J. Pharm. 309 2006 51 59 (Pubitemid 43129464)